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Introduction and objectives: Androgenetic alopecia in men (AGA) and female pattern 
hair loss (FPHL) are common hair loss causes which may heavily influence self-esteem 
and self-image. AGA and FPHL are caused by the heightened sensitivity of scalp 
follicles to dihydro-testosterone leading to dysregulation of downstream signaling 
cascades of inflammation. As a consequence a process of hair miniaturization develops 
over the time usually paralleled with a characteristic pattern distribution that varies 
between men and women. Histological observations showed perifollicular cells 
infiltrates and micro-inflammation. As this is a chronic condition, efficacy of products 
but also tolerability, cosmetic acceptance and patient satisfaction are key to ensure a 
good compliance. 
The aim of this study was to assess the benefit and tolerability of Aminexil clinical 5 
(AC5, containing Aminexil, Arginine, SP94, piroctone olamine and Vichy mineralizing 
water as active ingredients) in subjects with mild alopecia. 
Materials and methods: This was an open-label, observational, international study 
conducted in real life settings in 527 adult female and male subjects with mild alopecia. 
At baseline subjects underwent a clinical examination including Ludwig for female and 
Hamilton Norwood scoring for male subjects and received AC5 to be applied once daily 
for a minimum of 45 days. At the end of treatment, subjects assessed their hair growth 
and quality, satisfaction and local tolerance; investigators evaluated the impact of AC5 
on the subjects’ hair. 
Results: Data from 421 subjects were evaluable for the efficacy analysis. Tolerability 
data were available for 509 subjects. 58.7% of subjects were females; the mean age was 
34.1±9.1 years. Duration of hair loss was 1.3±1.8 years in women and 2.3±2.6 years, 
overall mean duration was 1.7±2.2 years. AC5 was used in combination with 
prescription treatments in 14.8% of cases (mainly topical) at inclusion with non-medical 
products (topicals and/or orals) in 42.2% of cases; 71.3% of women had a Ludwig score 
of 1 and 40.8% of males had a Hamilton Norwood score of 2. 
After a mean of 82.9±17.5 days of use dermatologist evaluation rated an improvement 
in hair loss in 87.1% of subjects compared to baseline; it was somewhat better in 
women (91.8%) than in men (80.3%). Subject satisfaction on a scale from 0 (not 
satisfied at all) to 10 (completely satisfied) was 7.9±1.7. Tolerance was good to very 
good in 98.6% of subjects. The texture was considered pleasant by 95% of subjects. 
Conclusion: In subjects with mild alopecia, AC5 reduces hair loss in both men and 
women with a pleasant texture. AC5 was well tolerated and highly appreciated by 
subjects and investigators. 
